etoposide has been researched along with sulfoquinovosyl diglyceride in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, S; Bhattacharyya, M; Chakrabarti, S; Jain, CK; Majumder, HK; Majumder, SS; Mondal, NB; Pradhan, BS; Roychoudhury, S | 1 |
1 other study(ies) available for etoposide and sulfoquinovosyl diglyceride
Article | Year |
---|---|
Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; DNA Replication; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Etoposide; Glycolipids; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Signal Transduction; Topoisomerase I Inhibitors; Tumor Suppressor Protein p53 | 2015 |